This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
Mark Your Calendar to Join Us Next Year September 23-26, 2024
Hynes Convention Center in BostonBoston, MA
Menu
Key Sessions
Craig Malzahn
Keynote: Commercial Manufacturing Strategies for Large-Market and Rare Disease AAV Gene Therapy Products
REGENXBIO Inc.
Ryan Bartock
Keynote – Addressing the Challenges of Transferring and Manufacturing Gene Therapies Externally and At-Scale
Spark Therapeutics
keyboard_arrow_right

Main Conference - Day 1 - EST/EDT (Eastern Daylight, GMT-4)

keyboard_arrow_leftSearch & Filter
search

Main Conference - Day 1 - EST/EDT (Eastern Daylight, GMT-4)

search
Showing 1 of 1 Streams
7:55am - 10:00am
CGT Opening Plenary Session in In Vivo Gene Therapy Room 205AB
Showing 1 of 1 Streams
10:55am - 11:00am
Chairperson's Opening Remarks
  • Lara Lonescu Silverman, PhD - Principal Consultant, LIS BioConsulting
11:00am - 11:30am
Keynote: Manufacturing and Process Development Strategies for Cell Therapies
  • Robert Zamboldi - Site Head, US Cell & Gene Therapy, Morris Plains NJ, Novartis
11:30am - 12:00pm
Creating a completely closed process solution from multi-vendor off-the-shelf process tools resulting in a low investment semi-automated workflow to compete with “all in one” cell processing systems for human MSC expansion, harvest, and final fill
  • Kyle Harvey, PharmD, PhD - Research Scientist, MED Institute Inc.
12:00pm - 12:30pm
Accelerating CAR-T Cell Manufacturing with a Next-Day Process and Automation
  • Xavier de Mollerat du Jeu - Senior Director, Research and Development, Thermo Fisher Scientific, USA
Showing 1 of 1 Streams
1:55pm - 2:00pm
Chairperson’s Remarks
  • Lara Lonescu Silverman, PhD - Principal Consultant, LIS BioConsulting
2:00pm - 3:00pm
Panel Discussion: Cell and Gene Therapy CDMO Selection and External Manufacturing Best Practices
  • Amish Patel, PhD - SVP Technical Operations, Calidi Biotherapeutics
  • Joseph Graskemper - Founder & Principal, Pathways Pharma Consulting, LLC
  • Brian Greven - Sr. Director of Operations, Matica Biotechnology Inc.
  • Catherine Tomaro-Duchesneau, PhD - Senior Director of Manufacturing Science & Technology, RoslinCT
  • Venkata Indurthi, PhD - Chief Scientific Officer, Aldevron
3:00pm - 3:30pm
Leveraging the TESSATM Technology for Versatile AAV Manufacturing
  • Seiga Ohmine - Head of Global Technical Sales, Wuxi Advanced Therapies
Pre-Conference Workshops
NextMain Conference - Day 2
Filter
Streams
Clear
Formats
Choose Day